BioSpace News Archive

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced its co-authorship of a study with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to be presented during the American Association for Cancer Research Annual Meeting 2022 from April 8-13, 2022.

Zynex, Inc. an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation and patient monitoring, announced that its board of directors approved a program to buy back $10.0 million of the Company’s common stock.

IsoPlexis Corporation, the Superhuman Cell Company, announced its preliminary unaudited revenue for the first quarter of 2022 and the transition to an integrated commercial and operational structure, which is intended to ensure a sustainable growth path.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Reef TA (TLIF Articulating) Interbody System.

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has commenced an underwritten public offering.